Focused on Every Breath

Diagnose Asthma with Confidence

Vivatmo pro
Provochonline
Provochonline Solution Logo

Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.

Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.

Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.

Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol), along with measuring the level of fractional exhaled nitric oxide (FeNO) in human breath using Vivatmo pro, are objective and evidence-based measures of airway hyperresponsiveness and inflammation. Both are key features of asthma. The right diagnosis is key.

As a committed partner, we also offer training and education (CRCE) at no cost to support clinicians as they help patients along their diagnostic journey.

Vivatmo pro logo

NOW AVAILABLE!

Provocholine Solution.

NOW AVAILABLE!

Is it Asthma?

Consider the consequences of an incorrect diagnosis of asthma:

E

Ineffective treatments

E

Inappropriate medications

E

Poor quality of life

E
Poor symptom control
E

Impact on work and school performance

Is it Asthma?

Consider the consequences of an incorrect diagnosis of asthma:

E

Ineffective treatments

E

Inappropriate medications

E

Poor quality of life

E
Poor symptom control
E

Impact on work and school performance

Blog

Asthma Guidelines: The Latest From GINA

Asthma Guidelines: The Latest From GINA

Gina Hoots, MSEd, RRT-ACCS, RPFT, CCSH, AE-C, CHC    The Global Initiative for Asthma, or GINA, guidelines are consideredthe gold standard for asthma care worldwide. This provides an overview of the key updates and takeaways of the most effective strategies to gain...

read more
Reflections from 2023

Reflections from 2023

As 2023 wraps up and enter the holiday season, it feels natural to reflect on the events of the year. This is a terrific opportunity to share why we are grateful. This is the second year of the Methapharm Respiratory Blog. We checked back with our authors from the...

read more
1. S.D. Aaron, K.L Vandemheen, et al. Reevaluation of Diagnosis in Adults with Physician-Diagnosed Asthma. JAMA. 2017 Jan 17;317(3):269-279.